Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

Carvedilol Associated with Lower Risk of Cirrhosis Complications Than Other Beta-Blockers

A retrospective cohort study of U.S. adults with cirrhosis found that treatment with the beta-blocker carvedilol was associated with meaningful lower rates of major decompensation events, such as fluid buildup, bleeding, or infection, within six months compared with those taking nadolol or propranolol.

July 6, 2026


July 15 2026

July 14 2026

July 13 2026

July 12 2026

July 10 2026

July 9 2026

July 8 2026

July 7 2026

July 6 2026

July 3 2026

July 2 2026

July 1 2026